3 results  1 of 1 

1 Prognostic Factor and Clinical Outcome in Stage III Non–Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population
Ho Cheol Kim, Wonjun Ji, Jae Cheol Lee, Hyeong Ryul Kim, Si Yeol Song, Chang-Min Choi
Cancer Res Treat.2021;53(4):1033-1041.   Published online 2021 February 16     DOI: http://dx.doi.org/10.4143/crt.2020.1350
      
2 The effects according to the timing of thoracic radiotherapyin limited stage small cell lung cancer
Sang Ki Park, Geun Hwa Kim, Seong Su Jeong, Kyoung Sang Shin, Ae Kyoung Kim, Hai Jeong Cho, Jee Won Suhr, Jae Sung Kim, Moon June Cho, Ju Ock Kim, Sun Young Kim
Tuberc Respir Dis.1996;43(6):903-915.   Published online 2016 March 15     DOI: http://dx.doi.org/10.4046/trd.1996.43.6.903
      
3 Phase II Study of Concurrent Chemotherapy with Etoposide and Cisplatin (EP) and Radiation Therapy for Unresectable Stage III Non-small Cell Lung Cancer
Nam Hyun Hur, Choon Taek Lee, Jae Hag Kim, Seung Mo Nam, Yeon Hee Park, Baek Yeol Ryoo, Tae You Kim, Young Hyuck Im, Yoon Koo Kang, Mi Sook Kim, Seong Yul Yoo, Jhin Oh Lee, Tae Woong Kang
Tuberc Respir Dis.1997;44(4):776-784.   Published online 2016 March 14     DOI: http://dx.doi.org/10.4046/trd.1997.44.4.776
      

 1 of 1